T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Match Group
MTCH
|
+$3.17B |
| 2 |
Nike
NKE
|
+$1.94B |
| 3 |
Bank of America
BAC
|
+$1.84B |
| 4 |
FedEx
FDX
|
+$1.78B |
| 5 |
PNC Financial Services
PNC
|
+$1.61B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPLI
People Inc
PPLI
|
+$4.1B |
| 2 |
Fortive
FTV
|
+$2.54B |
| 3 |
Linde
LIN
|
+$1.53B |
| 4 |
Alibaba
BABA
|
+$1.35B |
| 5 |
Willis Towers Watson
WTW
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.61% |
| 2 | Healthcare | 16.74% |
| 3 | Consumer Discretionary | 15.8% |
| 4 | Financials | 11.46% |
| 5 | Communication Services | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Mettler-Toledo International
MTD
$28.7B
| $137M | 0.02% |
141,844
+1,129
| +0.8% | +$1.05M |
|
577
CRISPR Therapeutics
CRSP
$5.22B
| $136M | 0.02% |
1,630,932
+255,605
| +19% | +$22.7M |
|
578
Ecolab
ECL
$77.4B
| $136M | 0.02% |
680,859
-18,331
| -3% | -$3.66M |
|
579
NovoCure
NVCR
$2.02B
| $135M | 0.02% |
1,215,318
+34,051
| +3% | +$2.72M |
|
580
Allogene Therapeutics
ALLO
$683M
| $135M | 0.02% |
3,577,684
-213,102
| -6% | -$8.03M |
|
581
Equity Lifestyle Properties
ELS
$12.6B
| $134M | 0.02% |
2,180,921
+102,093
| +5% | +$6.61M |
|
582
Monro
MNRO
$352M
| $132M | 0.02% |
3,263,357
-297,603
| -8% | -$15.2M |
|
583
LCI Industries
LCII
$2.6B
| $131M | 0.02% |
1,229,198
+4,804
| +0.4% | +$559K |
|
584
Douglas Emmett
DEI
$1.99B
| $131M | 0.02% |
5,203,687
-1,152,546
| -18% | -$32.5M |
|
585
CDW
CDW
$17.8B
| $129M | 0.01% |
1,080,354
-38,264
| -3% | -$4.38M |
|
|
GBIO
586
DELISTED
Generation Bio
GBIO
| $129M | 0.01% |
432,096
+13,978
| +3% | +$3.34M |
|
587
Prosperity Bancshares
PB
$8.97B
| $128M | 0.01% |
2,476,190
-8,582
| -0.3% | -$470K |
|
|
CCMP
588
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $128M | 0.01% |
895,389
-2,955
| -0.3% | -$441K |
|
|
FRC
589
DELISTED
First Republic Bank
FRC
| $128M | 0.01% |
1,169,385
-155,237
| -12% | -$17.2M |
|
590
BP
BP
$110B
| $127M | 0.01% |
7,282,321
+2,609
| +0% | +$56.5K |
|
591
Enerpac Tool Group
EPAC
$1.89B
| $127M | 0.01% |
6,758,433
+2,610,729
| +63% | +$52.1M |
|
592
Tyler Technologies
TYL
$13.5B
| $126M | 0.01% |
360,420
+18,577
| +5% | +$6.42M |
|
593
GoodRx Holdings
GDRX
$1.27B
| $125M | 0.01% |
+2,250,000
| New | +$119M |
|
594
McKesson
MCK
$99.9B
| $124M | 0.01% |
835,543
+220,209
| +36% | +$33.4M |
|
595
Zebra Technologies
ZBRA
$18B
| $123M | 0.01% |
488,683
-215
| -0% | -$57.9K |
|
596
SelectQuote
SLQT
$126M
| $122M | 0.01% |
6,139,291
+121,171
| +2% | +$2.52M |
|
597
Yum China
YUMC
$16.2B
| $122M | 0.01% |
2,301,806
-257,405
| -10% | -$13.6M |
|
598
Liberty Energy
LBRT
$3.45B
| $121M | 0.01% |
15,136,985
+107,457
| +0.7% | +$748K |
|
599
Brighthouse Financial
BHF
$3.42B
| $121M | 0.01% |
4,486,467
+465,367
| +12% | +$13.5M |
|
600
FB Financial Corp
FBK
$3.1B
| $121M | 0.01% |
4,799,072
+376,894
| +9% | +$9.75M |
|
Similar funds
T. Rowe Price Associates's Q3 2020 Portfolio in Review
As of Q3 2020, T. Rowe Price Associates held 2,679 positions worth $864B, up 8.7% from $795B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2020 filing shows 185 new, 873 increased, 1,330 reduced and 90 closed positions. Its largest new stake was nCino: 5,133,240 shares worth $395M. The largest sale was People Inc, an estimated $4.1B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2020 buy was nCino: 5,133,240 shares worth $395M.
- T. Rowe Price Associates added most to Match Group in Q3 2020, an estimated $3.17B increase.
- T. Rowe Price Associates's biggest Q3 2020 reduction was People Inc, cutting an estimated $4.1B.
- T. Rowe Price Associates fully exited 58.com Inc in Q3 2020, selling an estimated $468M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $864B portfolio in Q3 2020.
- T. Rowe Price Associates opened 185 new positions and closed 90 in Q3 2020.
- T. Rowe Price Associates's portfolio value rose 8.7% quarter-over-quarter to $864B.
Based on T. Rowe Price Associates's 13F filing for Q3 2020, filed 16 Nov 2020.